-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
-
Summary
-
Contineum Therapeutics, Inc. quarterly Liabilities and Equity history and growth rate from Q4 2023 to Q2 2024.
- Contineum Therapeutics, Inc. Liabilities and Equity for the quarter ending June 30, 2024 was $221M.